ZNF216 is an A20-like and IκB Kinase Γ-Interacting Inhibitor of NFκB Activation
Jun Huang,Lin Teng,Lixia Li,Ting Liu,Lianyun Li,Danying Chen,Liang-Guo Xu,Zhonghe Zhai,Hong-Bing Shu
DOI: https://doi.org/10.1074/jbc.m309491200
IF: 5.485
2004-01-01
Journal of Biological Chemistry
Abstract:The transcription factor NFκB plays important roles in immune regulation, inflammatory responses, and anti-apoptosis. Activation of NFκB requires the activity of IκB kinase, a kinase complex that contains two catalytic subunits, IKKα and IKKβ, and a non-enzymatic regulatory subunit, IKKγ. To understand how NFκB activation is regulated at the IKKγ level, we searched for IKKγ-interacting proteins by the yeast two-hybrid system. This search identified ZNF216, a zinc finger protein with unknown biological functions. ZNF216 contains an A20-like zinc finger domain (ZnF-A20) at its N terminus and an AN1-like domain (ZnF-AN1) at its C terminus. Similar to A20, ZNF216 interacted with IKKγ, RIP, and TRAF6 in co-immunoprecipitation experiments. Domain mapping experiments indicated that the ZnF-A20 domain was responsible for interacting with IKKγ and RIP, whereas the ZnF-AN1 domain interacted with TRAF6. ZNF216 inhibited NFκB activation triggered by overexpression of RIP and TRAF6 but not of p65. ZNF216 also inhibited tumor necrosis factor (TNF)-, interleukin-1-, and Toll-like receptor 4-induced NFκB activation in a dose-dependent manner. The ZnF-A20 domain was essential for ZNF216-mediated inhibition of NFκB activation. The ZnF-A20 and ZnF-AN1 domains of ZNF216 could interact with each other, whereas ZNF216 could form homo-oligomers or hetero-oligomers with A20. Unlike A20, which inhibits TNF-induced apoptosis, overexpression of ZNF216 sensitized cells to TNF-induced apoptosis. Our findings suggest that ZNF216 and A20 have redundant and distinct roles in regulating NFκB activation and apoptosis. The transcription factor NFκB plays important roles in immune regulation, inflammatory responses, and anti-apoptosis. Activation of NFκB requires the activity of IκB kinase, a kinase complex that contains two catalytic subunits, IKKα and IKKβ, and a non-enzymatic regulatory subunit, IKKγ. To understand how NFκB activation is regulated at the IKKγ level, we searched for IKKγ-interacting proteins by the yeast two-hybrid system. This search identified ZNF216, a zinc finger protein with unknown biological functions. ZNF216 contains an A20-like zinc finger domain (ZnF-A20) at its N terminus and an AN1-like domain (ZnF-AN1) at its C terminus. Similar to A20, ZNF216 interacted with IKKγ, RIP, and TRAF6 in co-immunoprecipitation experiments. Domain mapping experiments indicated that the ZnF-A20 domain was responsible for interacting with IKKγ and RIP, whereas the ZnF-AN1 domain interacted with TRAF6. ZNF216 inhibited NFκB activation triggered by overexpression of RIP and TRAF6 but not of p65. ZNF216 also inhibited tumor necrosis factor (TNF)-, interleukin-1-, and Toll-like receptor 4-induced NFκB activation in a dose-dependent manner. The ZnF-A20 domain was essential for ZNF216-mediated inhibition of NFκB activation. The ZnF-A20 and ZnF-AN1 domains of ZNF216 could interact with each other, whereas ZNF216 could form homo-oligomers or hetero-oligomers with A20. Unlike A20, which inhibits TNF-induced apoptosis, overexpression of ZNF216 sensitized cells to TNF-induced apoptosis. Our findings suggest that ZNF216 and A20 have redundant and distinct roles in regulating NFκB activation and apoptosis. Nuclear factor κB (NFκB) 1The abbreviations used are: NFκB, nuclear factor κB; IKK, IκB kinase; ZnF-AN1, AN1-like zinc finger; TNF, tumor necrosis factor; IL, interleukin; ZnF-A20, A20-like zinc finger; IFN, interferon; X-gal, 5-bromo-4-chloro-3-indolyl-β-d-galactopyranoside; HA, hemagglutinin; CMV, cytomegalovirus. 1The abbreviations used are: NFκB, nuclear factor κB; IKK, IκB kinase; ZnF-AN1, AN1-like zinc finger; TNF, tumor necrosis factor; IL, interleukin; ZnF-A20, A20-like zinc finger; IFN, interferon; X-gal, 5-bromo-4-chloro-3-indolyl-β-d-galactopyranoside; HA, hemagglutinin; CMV, cytomegalovirus. proteins are inducible transcription factors involved in a broad range of physiological and pathological processes (1Karin M. Ben-Neriah Y. Annu. Rev. Immunol. 2000; 18: 621-663Crossref PubMed Scopus (4045) Google Scholar, 2Baldwin A.S. J. Clin. Investig. 2001; 107: 241-246Crossref PubMed Scopus (1189) Google Scholar, 3Ghosh S. Karin M. Cell. 2002; 109: S81-S96Abstract Full Text Full Text PDF PubMed Scopus (3274) Google Scholar, 4Karin M. Lin A. Nature Immunol. 2002; 3: 221-222Crossref PubMed Scopus (2433) Google Scholar). For example, NFκB plays critical roles in immune regulation and inflammation through induction of a large set of downstream genes, including cytokines, chemokines, adhesion molecules, and effectors (1Karin M. Ben-Neriah Y. Annu. Rev. Immunol. 2000; 18: 621-663Crossref PubMed Scopus (4045) Google Scholar, 2Baldwin A.S. J. Clin. Investig. 2001; 107: 241-246Crossref PubMed Scopus (1189) Google Scholar, 3Ghosh S. Karin M. Cell. 2002; 109: S81-S96Abstract Full Text Full Text PDF PubMed Scopus (3274) Google Scholar, 4Karin M. Lin A. Nature Immunol. 2002; 3: 221-222Crossref PubMed Scopus (2433) Google Scholar). Recent studies suggest that NFκB also is critically involved in the regulation of cell death and survival through the transcriptional activation of genes important for anti-apoptosis and cell proliferation, such as Casper/c-FLIP, c-IAPs, TRAF1, TRAF2, Bfl-1/A1, Bcl-Xl, Fas ligand, c-myc, and cyclin D1 (1Karin M. Ben-Neriah Y. Annu. Rev. Immunol. 2000; 18: 621-663Crossref PubMed Scopus (4045) Google Scholar, 2Baldwin A.S. J. Clin. Investig. 2001; 107: 241-246Crossref PubMed Scopus (1189) Google Scholar, 3Ghosh S. Karin M. Cell. 2002; 109: S81-S96Abstract Full Text Full Text PDF PubMed Scopus (3274) Google Scholar, 4Karin M. Lin A. Nature Immunol. 2002; 3: 221-222Crossref PubMed Scopus (2433) Google Scholar).NFκB contains five members in mammals, Rel (c-Rel), RelA (p65), RelB, NFκB1 (p50 and its precursor p105), and NFκB2 (p52 and its precursor p100) (1Karin M. Ben-Neriah Y. Annu. Rev. Immunol. 2000; 18: 621-663Crossref PubMed Scopus (4045) Google Scholar, 2Baldwin A.S. J. Clin. Investig. 2001; 107: 241-246Crossref PubMed Scopus (1189) Google Scholar, 3Ghosh S. Karin M. Cell. 2002; 109: S81-S96Abstract Full Text Full Text PDF PubMed Scopus (3274) Google Scholar, 4Karin M. Lin A. Nature Immunol. 2002; 3: 221-222Crossref PubMed Scopus (2433) Google Scholar). The major cellular form of NFκB is a heterodimer consisting of the DNA binding subunit p50 and the transactivator p65. Normally, NFκB is retained in the cytoplasm through association with its inhibitor IκB. Upon stimulation by various NFκB activating signals, IκB is phosphorylated and degraded through a ubiquitin-dependent process. This process frees NFκB, which is then translocated into the nucleus to activate transcription of downstream genes (1Karin M. Ben-Neriah Y. Annu. Rev. Immunol. 2000; 18: 621-663Crossref PubMed Scopus (4045) Google Scholar, 2Baldwin A.S. J. Clin. Investig. 2001; 107: 241-246Crossref PubMed Scopus (1189) Google Scholar, 3Ghosh S. Karin M. Cell. 2002; 109: S81-S96Abstract Full Text Full Text PDF PubMed Scopus (3274) Google Scholar, 4Karin M. Lin A. Nature Immunol. 2002; 3: 221-222Crossref PubMed Scopus (2433) Google Scholar).Phosphorylation of IκB is mediated by a kinase complex, called IκB kinase (IKK) (5Didonato J.A. Hayakawa M. Rothwarf D.M. Zandi E. Karin M. Nature. 1997; 388: 548-554Crossref PubMed Scopus (1897) Google Scholar, 6Mercurio F. Zhu H. Murray B.W. Shevchenko A. Bennett B.L. Li J. Young D.B. Barbosa M. Manning A. Rao A. Science. 1997; 278: 860-866Crossref PubMed Scopus (1840) Google Scholar, 7Regnier C.H. Song H.Y. Gao X. Goeddel D.V. Cao Z. Rothe M. Cell. 1997; 90: 373-383Abstract Full Text Full Text PDF PubMed Scopus (1069) Google Scholar, 8Rothwarf D.M. Zandi E. Natoli G. Karin M. Nature. 1998; 395: 297-330Crossref PubMed Scopus (842) Google Scholar, 9Woronicz J.D. Gao X. Cao Z. Rothe M. Goeddel D.V. Science. 1997; 278: 866-869Crossref PubMed Scopus (1063) Google Scholar, 10Zandi E. Rothwarf D.M. Delhase M. Hayakawa M. Karin M. Cell. 1997; 91: 243-252Abstract Full Text Full Text PDF PubMed Scopus (1571) Google Scholar). IKK contains two catalytic subunits, IKKα (IKK1) and IKKβ (IKK2), and a non-enzymatic regulatory subunit IKKγ (NEMO) (5Didonato J.A. Hayakawa M. Rothwarf D.M. Zandi E. Karin M. Nature. 1997; 388: 548-554Crossref PubMed Scopus (1897) Google Scholar, 6Mercurio F. Zhu H. Murray B.W. Shevchenko A. Bennett B.L. Li J. Young D.B. Barbosa M. Manning A. Rao A. Science. 1997; 278: 860-866Crossref PubMed Scopus (1840) Google Scholar, 7Regnier C.H. Song H.Y. Gao X. Goeddel D.V. Cao Z. Rothe M. Cell. 1997; 90: 373-383Abstract Full Text Full Text PDF PubMed Scopus (1069) Google Scholar, 8Rothwarf D.M. Zandi E. Natoli G. Karin M. Nature. 1998; 395: 297-330Crossref PubMed Scopus (842) Google Scholar, 9Woronicz J.D. Gao X. Cao Z. Rothe M. Goeddel D.V. Science. 1997; 278: 866-869Crossref PubMed Scopus (1063) Google Scholar, 10Zandi E. Rothwarf D.M. Delhase M. Hayakawa M. Karin M. Cell. 1997; 91: 243-252Abstract Full Text Full Text PDF PubMed Scopus (1571) Google Scholar, 11Yamaoka S. Courtois G. Bessia C. Whiteside S.T. Weil R. Agou F. Kirt H.E. Kay R.J. Israel A. Cell. 1998; 93: 1231-1240Abstract Full Text Full Text PDF PubMed Scopus (945) Google Scholar). It has been proposed that IKKγ is responsible for connecting IKK to upstream signaling components in various NFκB activation pathways (1Karin M. Ben-Neriah Y. Annu. Rev. Immunol. 2000; 18: 621-663Crossref PubMed Scopus (4045) Google Scholar, 2Baldwin A.S. J. Clin. Investig. 2001; 107: 241-246Crossref PubMed Scopus (1189) Google Scholar, 3Ghosh S. Karin M. Cell. 2002; 109: S81-S96Abstract Full Text Full Text PDF PubMed Scopus (3274) Google Scholar, 4Karin M. Lin A. Nature Immunol. 2002; 3: 221-222Crossref PubMed Scopus (2433) Google Scholar). For example, it has been shown that IKKγ interacts directly with RIP in the TNF-R1 signaling complex and with TRAF6 in the Toll-interleukin-1 receptor signaling complexes (12Devin A. Cook A. Lin Y. Rodriguez Y. Kelliher M. Liu Z. Immunity. 2000; 12: 419-429Abstract Full Text Full Text PDF PubMed Scopus (355) Google Scholar, 13Zhang S.Q. Kovalenko A. Cantarella G. Wallach D. Immunity. 2000; 12: 301-311Abstract Full Text Full Text PDF PubMed Scopus (392) Google Scholar, 14Inohara N. Koseki T. Lin J. del Peso L. Lucas P.C. Chen F.F. Ogura Y. Nunez G. J. Biol. Chem. 2000; 275: 27823-27831Abstract Full Text Full Text PDF PubMed Scopus (449) Google Scholar, 15Poyet J.L. Srinivasula S.M. Lin J.H. Fernandes-Alnemri T. Yamaoka S. Tsichlis P.N. Alnemri E.S. J. Biol. Chem. 2000; 275: 37966-37977Abstract Full Text Full Text PDF PubMed Scopus (145) Google Scholar). Gene knock-out studies have demonstrated that IKKγ is required for NFκB activation triggered by all tested stimuli (11Yamaoka S. Courtois G. Bessia C. Whiteside S.T. Weil R. Agou F. Kirt H.E. Kay R.J. Israel A. Cell. 1998; 93: 1231-1240Abstract Full Text Full Text PDF PubMed Scopus (945) Google Scholar). Thus, IKKγ represents a critical regulatory point in NFκB activation pathways.A number of molecules, such as A20 (16Opipari Jr., A.W. Boguski M.S. Dixit V.M. J. Biol. Chem. 1990; 265: 14705-14708Abstract Full Text PDF PubMed Google Scholar, 17Heyninck K. Beyaert R. FEBS Lett. 1999; 442: 147-150Crossref PubMed Scopus (149) Google Scholar, 18Heyninck K. Valck D.D. Vanden Berghe W. van Criekinge W. Contreras R.R. Fiers W. Haegeman G. Beyaert R. J. Cell Biol. 1999; 145: 1471-1482Crossref PubMed Scopus (252) Google Scholar, 19Jäättelä M. Mouritzen H. Elling F. Bastholm L. J. Immunol. 1996; 156: 1166-1173PubMed Google Scholar, 20Klinkenberg M. Huffel S.V. Heyninck K. Beyaert R. FEBS Lett. 2001; 498: 93-97Crossref PubMed Scopus (65) Google Scholar, 21Lee E.G. Boone D.L. Chai S. Libby S.L. Chien M. Lodolce J.P. Ma A. Science. 2000; 289: 2350-2354Crossref PubMed Scopus (1178) Google Scholar, 22Song H.Y. Rothe M. Goeddel D.V. Proc. Natl. Acad. Sci. U. S. A. 1996; 93: 6721-6725Crossref PubMed Scopus (368) Google Scholar), ZIN (23Chen D. Li X. Zhai Z. Shu H.B. J. Biol. Chem. 2002; 277: 15985-15991Abstract Full Text Full Text PDF PubMed Scopus (55) Google Scholar), SINK (24Wu M. Xu L.G. Zhai Z. Shu H.B. J. Biol. Chem. 2003; 278: 27072-27079Abstract Full Text Full Text PDF PubMed Scopus (96) Google Scholar), ABIN1 (18Heyninck K. Valck D.D. Vanden Berghe W. van Criekinge W. Contreras R.R. Fiers W. Haegeman G. Beyaert R. J. Cell Biol. 1999; 145: 1471-1482Crossref PubMed Scopus (252) Google Scholar), and ABIN2 (25Van Huffel S. Delaei F. Heyninck K. De Valck D. Beyaert R. J. Biol. Chem. 2001; 276: 30216-30223Abstract Full Text Full Text PDF PubMed Scopus (80) Google Scholar), have been implicated in negative regulation of NFκB activation pathways. A20 was originally identified as a tumor necrosis factor (TNF)-responsive gene in human endothelial cells (16Opipari Jr., A.W. Boguski M.S. Dixit V.M. J. Biol. Chem. 1990; 265: 14705-14708Abstract Full Text PDF PubMed Google Scholar). A20 contains seven novel zinc finger motifs with characteristics of CX2-4CX11CX2C at its C-terminal domain (16Opipari Jr., A.W. Boguski M.S. Dixit V.M. J. Biol. Chem. 1990; 265: 14705-14708Abstract Full Text PDF PubMed Google Scholar). It has been shown that A20 interacts with RIP, IKKγ, and TRAF6 (13Zhang S.Q. Kovalenko A. Cantarella G. Wallach D. Immunity. 2000; 12: 301-311Abstract Full Text Full Text PDF PubMed Scopus (392) Google Scholar, 17Heyninck K. Beyaert R. FEBS Lett. 1999; 442: 147-150Crossref PubMed Scopus (149) Google Scholar, 18Heyninck K. Valck D.D. Vanden Berghe W. van Criekinge W. Contreras R.R. Fiers W. Haegeman G. Beyaert R. J. Cell Biol. 1999; 145: 1471-1482Crossref PubMed Scopus (252) Google Scholar). Overexpression of A20 inhibits NFκB activation triggered by various stimuli, including TNF, IL-1, and lipopolysaccharide (16Opipari Jr., A.W. Boguski M.S. Dixit V.M. J. Biol. Chem. 1990; 265: 14705-14708Abstract Full Text PDF PubMed Google Scholar, 17Heyninck K. Beyaert R. FEBS Lett. 1999; 442: 147-150Crossref PubMed Scopus (149) Google Scholar, 18Heyninck K. Valck D.D. Vanden Berghe W. van Criekinge W. Contreras R.R. Fiers W. Haegeman G. Beyaert R. J. Cell Biol. 1999; 145: 1471-1482Crossref PubMed Scopus (252) Google Scholar, 19Jäättelä M. Mouritzen H. Elling F. Bastholm L. J. Immunol. 1996; 156: 1166-1173PubMed Google Scholar, 20Klinkenberg M. Huffel S.V. Heyninck K. Beyaert R. FEBS Lett. 2001; 498: 93-97Crossref PubMed Scopus (65) Google Scholar, 21Lee E.G. Boone D.L. Chai S. Libby S.L. Chien M. Lodolce J.P. Ma A. Science. 2000; 289: 2350-2354Crossref PubMed Scopus (1178) Google Scholar, 22Song H.Y. Rothe M. Goeddel D.V. Proc. Natl. Acad. Sci. U. S. A. 1996; 93: 6721-6725Crossref PubMed Scopus (368) Google Scholar, 26O'Reilly S.M. Moynagh P.N. Biochem. Biophys. Res. Commun. 2003; 303: 586-593Crossref PubMed Scopus (50) Google Scholar). Gene knock-out studies have demonstrated that A20 is a suppressor of inflammation through attenuating TNF-induced NFκB activation (21Lee E.G. Boone D.L. Chai S. Libby S.L. Chien M. Lodolce J.P. Ma A. Science. 2000; 289: 2350-2354Crossref PubMed Scopus (1178) Google Scholar). A20 also can inhibit TNF-induced apoptosis, and a recent report suggests that this is mediated through disrupting recruitment of the death domain containing adapter proteins TRADD and RIP to the TNF receptor 1 signaling complex (27He K.L. Ting A.T. Mol. Cell. Biol. 2002; 22: 6034-6045Crossref PubMed Scopus (166) Google Scholar).In this report, we identified a novel IKKγ-interacting protein, ZNF216. ZNF216 contains an A20-like zinc finger (ZnFA20) domain at its N terminus and an AN1-like zinc finger (ZnF-AN1) domain at its C terminus. In addition to IKKγ, ZNF216 also interacts with RIP, TRAF6, and A20. Overexpression of ZNF216 inhibits NFκB activation triggered by TNF, IL-1, and Toll-like receptor 4 and sensitizes cells to TNF-induced apoptosis. Our findings suggest that ZNF216 and A20 have redundant and distinct functions in regulating NFκB activation and apoptosis.EXPERIMENTAL PROCEDURESReagents—Recombinant TNF, IL-1, and IFN-γ (R&D Systems Inc., Minneapolis, MN), mouse monoclonal antibodies against FLAG (Sigma) and HA (Covance, Berkeley, CA) epitopes, rabbit polyclonal antibodies against IKKγ and RIP (Santa Cruz Biotechnology, Santa Cruz, CA), human embryonic kidney 293 cells (ATCC, Manassas, VA), and the human leukocyte cDNA library (Clontech, Palo Alto, CA) were purchased from the indicated manufacturers.Constructs—The NFκB (Dr. Gary Johnson, University of Colorado Health Sciences Center) and IRF-1 (Dr. Uli Schindler, Tularik Inc.) luciferase reporter plasmids were provided by the indicated investigators. The mammalian expression plasmids for HA- or FLAG-tagged RIP, IKKβ, IKKγ, TRAF2, TRAF6, and p65 were previously described (23Chen D. Li X. Zhai Z. Shu H.B. J. Biol. Chem. 2002; 277: 15985-15991Abstract Full Text Full Text PDF PubMed Scopus (55) Google Scholar, 24Wu M. Xu L.G. Zhai Z. Shu H.B. J. Biol. Chem. 2003; 278: 27072-27079Abstract Full Text Full Text PDF PubMed Scopus (96) Google Scholar). The HA- or FLAG-tagged mammalian expression plasmids for ZNF216 and its mutants were constructed by PCR amplification of the corresponding cDNA fragments and subsequently cloning into a cytomegalovirus promoter-based vector containing an N-terminal HA or FLAG tag.Yeast Two-hybrid Screening—The cDNA encoding full-length human IKKγ was inserted in-frame into the Gal4 DNA binding domain vector pGBT9 (Clontech). The human leukocyte two-hybrid cDNA library was screened and the isolation of positive clones was performed by following the manufacturer's protocols.Northern Blot Analysis—Human multiple tissue mRNA blots were purchased from Clontech. The blots were hybridized with 32P-labeled ZNF216 cDNA in the rapid hybridization buffer (Clontech) under high stringency conditions.Transfection and Reporter Gene Assays—Transfection of 293 cells was performed with the standard calcium phosphate precipitation method (28Sambrook J. Fritch E.F. Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY1989Google Scholar). 293 cells (∼1 × 105) were seeded on 12-well (25 mm) dishes and were transfected the following day. Within the same experiment, each transfection was performed in triplicate, and where necessary, empty control plasmid was added to ensure that each transfection received the same amount of total DNA. To normalize for transfection efficiency, 0.25 μg of PRL-RSV-SV40 plasmid was added to each transfection. Dual specific luciferase reporter assays were performed using a luciferase assay kit (Promega, Madison, WI) by following the manufacturer's protocol. Firefly luciferase activities were normalized on the basis of Renilla luciferase expression levels.Co-immunoprecipitation and Western Blot Analysis—Transfected 293 cells from each 100-mm dish were lysed in 1 ml of lysis buffer (20 mm Tris, pH 7.5, 150 mm NaCl, 1% Triton, 1 mm EDTA, 10 μg/ml aprotinin, 10 μg/ml leupeptin, 1 mm phenylmethylsulfonyl fluoride). For each immunoprecipitation, a 0.4-ml aliquot of lysate was incubated with 0.5 μg of the indicated monoclonal antibody or control mouse IgG and 25 μl of a 1:1 slurry of Gamma Bind G Plus-Sepharose (Amersham Biosciences) for at least 2 h. The Sepharose beads were washed three times with 1 ml of lysis buffer containing 500 mm NaCl. The precipitates were fractionated on SDS-PAGE, and subsequent Western blot analysis was performed as described (23Chen D. Li X. Zhai Z. Shu H.B. J. Biol. Chem. 2002; 277: 15985-15991Abstract Full Text Full Text PDF PubMed Scopus (55) Google Scholar, 24Wu M. Xu L.G. Zhai Z. Shu H.B. J. Biol. Chem. 2003; 278: 27072-27079Abstract Full Text Full Text PDF PubMed Scopus (96) Google Scholar).Apoptosis Assays—β-Galactosidase co-transfection assays for determination of cell death were performed as described previously (29Hsu H. Shu H.B. Pan M.G. Goeddel D.V. Cell. 1996; 104: 487-501Google Scholar, 30Shu H.B. Halpins D.R. Goeddel D.V. Immunity. 1997; 6: 751-763Abstract Full Text Full Text PDF PubMed Scopus (367) Google Scholar). Briefly, 293 cells (∼1 × 105) were seeded on 12-well dishes and transfected the following day by calcium phosphate precipitation with 0.1 μg of pCMV-β-galactosidase plasmid and the indicated testing plasmids. Within the same experiment, each transfection was performed in triplicate, and where necessary, empty control plasmid was added to ensure each transfection received the same amount of DNA. Approximately 14 h after transfection, the cells were treated with TNF (20 ng/ml) or cycloheximide (10 μg/ml) or left untreated for 12 h. Cells were then stained with X-gal as described previously (29Hsu H. Shu H.B. Pan M.G. Goeddel D.V. Cell. 1996; 104: 487-501Google Scholar, 30Shu H.B. Halpins D.R. Goeddel D.V. Immunity. 1997; 6: 751-763Abstract Full Text Full Text PDF PubMed Scopus (367) Google Scholar). The number of survived blue cells from five representative viewing fields was determined microscopically. Data shown are averages and standard deviations of one representative experiment in which each transfection had been performed in triplicate.RESULTSIdentification of ZNF216 as an IKKγ-interacting Protein—To identify IKKγ-interacting proteins, we used the yeast two-hybrid system to screen a human leukocyte cell cDNA library with full-length IKKγ as bait. We screened a total of ∼6 × 106 independent clones and obtained 33 β-galactosidase positive clones. Thirteen of these clones encoded ZNF216, a zinc finger protein expressed from human chromosome 9q (31Scott D.A. Greinwald Jr., J.H. Marietta J.R. Drury S. Swiderski R.E. Vinas A. DeAngelis M.M. Carmi R. Ramesh A. Kraft M.L. Elbedour K. Skworak A.B. Friedman R.A. Srikumari Srisailapathy C.R. Verhoeven K. Van Gamp G. Lovett M. Deininger P.L. Batzer M.A. Morton C.C. Keats B.J. Smith R.J. Sheffield V.C. Gene (Amst.). 1998; 215: 461-469Crossref PubMed Scopus (28) Google Scholar). The biological functions of ZNF216 are unknown.Sequence analysis suggested that ZNF216 was a 213 amino acid protein and contained two zinc finger domains (Fig. 1A). One zinc finger domain, ZnF-A20, was localized at amino acids 11-35 at the N terminus. ZnF-A20 contains a pattern of CX2-4-CX11CX2C that is similar to those found in A20, a zinc finger protein inhibiting TNF-induced NFκB activation and apoptosis (16Opipari Jr., A.W. Boguski M.S. Dixit V.M. J. Biol. Chem. 1990; 265: 14705-14708Abstract Full Text PDF PubMed Google Scholar, 17Heyninck K. Beyaert R. FEBS Lett. 1999; 442: 147-150Crossref PubMed Scopus (149) Google Scholar, 18Heyninck K. Valck D.D. Vanden Berghe W. van Criekinge W. Contreras R.R. Fiers W. Haegeman G. Beyaert R. J. Cell Biol. 1999; 145: 1471-1482Crossref PubMed Scopus (252) Google Scholar, 19Jäättelä M. Mouritzen H. Elling F. Bastholm L. J. Immunol. 1996; 156: 1166-1173PubMed Google Scholar, 20Klinkenberg M. Huffel S.V. Heyninck K. Beyaert R. FEBS Lett. 2001; 498: 93-97Crossref PubMed Scopus (65) Google Scholar, 21Lee E.G. Boone D.L. Chai S. Libby S.L. Chien M. Lodolce J.P. Ma A. Science. 2000; 289: 2350-2354Crossref PubMed Scopus (1178) Google Scholar, 22Song H.Y. Rothe M. Goeddel D.V. Proc. Natl. Acad. Sci. U. S. A. 1996; 93: 6721-6725Crossref PubMed Scopus (368) Google Scholar). Another zinc finger domain, ZnF-AN1, was localized at amino acids 154-193 at the C terminus. ZnF-AN1 contains a pattern of CX2CX9-12CX1-2CX4CX2HX5HXC that is similar to that of AN1, a ubiquitin-like protein in Xenopus laevis (32Linnen J.M. Bailey C.P. Weeks D.L. Gene (Amst.). 1993; 128: 181-188Crossref PubMed Scopus (74) Google Scholar). The intermediate fragment of ZNF216 had no significant homology with known proteins.Tissue Distribution and Protein Expression of ZNF216— Northern blot analysis suggested that human ZNF216 mRNA was highly expressed in skeletal muscle. It was weakly expressed or undetectable in the brain, heart, colon, thymus, spleen, kidney, liver, small intestine, placenta, lung, and peripheral blood leukocytes (Fig. 1B).To determine whether ZNF216 was expressed in mammalian cells at the protein level, we raised a rabbit polyclonal antiserum against recombinant full-length ZNF216. Western blot analysis suggested that ZNF216 was expressed as an ∼33-kDa protein in both human rhabdomyosarcoma RD cells and mouse myoblast C2C12 cells (Fig. 1C).ZNF216 Interacted with IKKγ, RIP, and TRAF6 in Mammalian Cells—To determine whether ZNF216 interacts with IKKγ in mammalian cells, we transfected 293 cells with expression plasmids for FLAG-tagged ZNF216 and HA-tagged IKKγ and IKKβ and performed co-immunoprecipitation experiments. These experiments indicated that full-length ZNF216 interacted specifically with IKKγ (Fig. 2A) but not IKKβ (data not shown).Fig. 2ZNF216 interacts with IKKγ, RIP, and TRAF6 but not TRAF2.A, ZNF216 and its ZnF-A20 domain interact with IKKγ. 293 cells (∼2 × 106) were transfected with 3 μg of an expression plasmid for HA-tagged IKKγ, together with 3 μg of an expression plasmid for FLAG-tagged ZNF216 or its mutants, ZNF216-(1-153) or ZNF216-(36-213). Cell lysates were immunoprecipitated with anti-FLAG antibody (αF) or control IgG (C), and Western blot analysis was performed with anti-HA antibody. Expression of IKKγ was confirmed by Western blot analysis of the lysate (L) with anti-HA antibody. Expression of ZNF216 and its mutants was comparable as indicated by Western blot analysis of the lysates with anti-FLAG antibody (data not shown). B, ectopically expressed ZNF216 interacts with endogenous IKKγ. 293 cells (∼1 × 107) were transfected with 20 μg of an expression plasmid for ZNF216 for 24 h. Cells were lysed, and the lysate was immunoprecipitated with anti-ZNF216 antibody or preimmune serum (C). The immunoprecipitate was analyzed by Western blot with anti-IKKγ antibody. C, ZNF216 and its ZnF-A20 domain interact with RIP. The same experiments were performed as in A, except that HA-tagged IKKγ was replaced with HA-tagged RIP. D, ectopically expressed ZNF216 interacts with endogenous RIP. 293 cells (∼1 × 107) were transfected with 20 μg of an expression plasmid for ZNF216 for 24 h. Cells were lysed, and the lysate was immunoprecipitated with anti-ZNF216 antibody or preimmune serum (C). The immunoprecipitate was analyzed by Western blot with anti-RIP antibody. E, ZNF216 interacts with TRAF6 but not TRAF2. 293 cells (∼2 × 106) were transfected with 3 μg of an expression plasmid for FLAG-tagged TRAF6 (left panel) or FLAG-tagged TRAF2 (right panel), together with 3 μg of an expression plasmid for HA-tagged ZNF216. Cell lysates were immunoprecipitated with anti-FLAG antibody (αF) or control IgG (C), and Western blot analysis was performed with anti-HA and anti-FLAG antibodies. Expression of the indicated plasmids was confirmed by Western blot analysis of the lysates (L) with anti-HA and anti-FLAG antibodies. F, TRAF6 interacts with the ZnF-AN1 domain of ZNF216. 293 cells (∼2 × 106) were transfected with 3 μg of an expression plasmid for FLAG-tagged TRAF6, together with 3 μg of an expression plasmid for HA-tagged ZNF216-(1-153) or ZNF216-(36-213). Cell lysates were immunoprecipitated with anti-FLAG antibody (αF) or control IgG (C), and Western blot analysis was performed with anti-HA and anti-FLAG antibodies. Expression of the indicated plasmids was confirmed by Western blot analysis of the lysates (L) with anti-HA and anti-FLAG antibodies. The above experiments were repeated three times, and similar results were obtained.View Large Image Figure ViewerDownload Hi-res image Download (PPT)We further examined whether endogenous ZNF216 and IKKγ interact in untransfected cells in the presence or absence of TNF. These experiments failed to detect their interaction (data not shown). One explanation is that our polyclonal anti-ZNF216 antibody is not potent enough for this type of experiment, which requires high quality antibodies. Then we examined whether ectopically expressed FLAG-tagged ZNF216 could interact with endogenous IKKγ. The results indicated that ectopically expressed ZNF216 could interact with endogenous IKKγ in 293 cells (Fig. 2B) and that this interaction was not affected by TNF stimulation (data not shown). In these experiments, IKKγ was shown as two bands around 48 kDa, which is consistent with previous reports (8Rothwarf D.M. Zandi E. Natoli G. Karin M. Nature. 1998; 395: 297-330Crossref PubMed Scopus (842) Google Scholar, 11Yamaoka S. Courtois G. Bessia C. Whiteside S.T. Weil R. Agou F. Kirt H.E. Kay R.J. Israel A. Cell. 1998; 93: 1231-1240Abstract Full Text Full Text PDF PubMed Scopus (945) Google Scholar).To determine which domain is responsible for the interaction of ZNF216 with IKKγ, we made ZNF216 deletion mutants containing either ZnF-A20 (amino acids 1-153) or ZnF-AN1 (amino acids 36-213) and performed co-immunoprecipitation experiments. The results indicated that ZnF-A20 but not ZnF-AN1 was required for the interaction of ZNF216 with IKKγ (Fig. 2A).It has been reported that A20 interacts with RIP in the TNF-R1 complex and TRAF6 in the Toll-interleukin-1 receptor signaling complexes. Because ZNF216 contains an A20-like zinc finger domain, we determined whether ZNF216 can also interact with RIP and TRAF6. To test this possibility, we transfected 293 cells with an expression plasmid for ZNF216 together with an expression plasmid for RIP, TRAF6, or TRAF2. Co-immunoprecipitation experiments indicated that ZNF216 interacted with RIP (Fig. 2C) and TRAF6 (Fig. 2E) but not TRAF2 (Fig. 2E). Furthermore, ectopically expressed ZNF216 interacted with endogenous RIP in 293 cells (Fig. 2D). Domain mapping experiments further indicated that ZnF-A20 was required for the interaction of ZNF216 with RIP (Fig. 2C), whereas ZnF-AN1 was required for the interaction of ZNF216 with TRAF6 (Fig. 2F).ZNF216 Inhibited RIP- and TRAF6-